Protocol 6. Management of hepatitis C and HIV coinfection




In Europe, the prevalence of hepatitis C virus (HCV) infection in HIV-infected patients is particularly high – and still rising, in contrast to the rest of the world. Yet only a minority of HCV/HIVcoinfected
patients are treated for their hepatitis. The compounding effect of coinfection makes the care for these patients a major challenge.